Literature DB >> 8400669

Natural killer activity and serum immunosuppressive acidic protein levels in esophageal and gastric cancers.

M Oka1, H Mitsunaga, S Hazama, S Yoshino, T Suzuki.   

Abstract

The natural killer (NK) activity of peripheral blood mononuclear cells and serum immunosuppressive acidic protein (IAP) levels were examined in patients with esophageal or gastric cancer, before and after surgery. Patients with stage IV esophageal or stage IV gastric cancer had significantly lower NK activity (39.5 +/- 14.8% and 37 +/- 11.6%, respectively), and also higher serum IAP levels (778 +/- 264 micrograms/mL and 633 +/- 156 micrograms/mL, respectively), than the corresponding control values (50 +/- 5.6% and 375 +/- 26 micrograms/mL, respectively). Patients with esophageal or gastric cancer who underwent curative resection had high NK activity (54.8 +/- 11.6% and 54.8 +/- 8.0%, respectively), and low IAP levels (471 +/- 116 micrograms/mL and 490 +/- 42 micrograms/mL, respectively), compared with those who underwent non-curative resection. Patients who underwent non-curative resection had lower NK activity and higher serum IAP levels than those who underwent curative resection, even 1 month after surgery. Mononuclear cells in the regional lymph nodes and tumor specimens showed significantly lower NK activity than those in the peripheral blood and spleen. Thus, NK activity and the IAP level reflected the immunocompetence, clinical course, and surgical curability of those patients. NK cells appeared not to have any significant antitumor activity in the regional lymph nodes or in the tumor itself, although they were still active in the peripheral blood.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8400669     DOI: 10.1007/bf00311703

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

1.  Guide lines for the clinical and pathologic studies on carcinoma of the esophagus.

Authors: 
Journal:  Jpn J Surg       Date:  1976-06

2.  Natural killer cells: definition of a cell type rather than a function.

Authors:  L L Lanier; J H Phillips; J Hackett; M Tutt; V Kumar
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

3.  The effect of surgery and chemotherapy on blood NK cell activity in patients with ovarian cancer.

Authors:  B Lukomska; W L Olszewski; A Engeset; P Kolstad
Journal:  Cancer       Date:  1983-02-01       Impact factor: 6.860

4.  The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification.

Authors:  T Kajitani
Journal:  Jpn J Surg       Date:  1981-03

5.  Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients.

Authors:  K Tamura; Y Shibata; Y Matsuda; N Ishida
Journal:  Cancer Res       Date:  1981-08       Impact factor: 12.701

6.  Immunosuppressive acidic protein (IAP) in gastric cancer patients.

Authors:  N Shimizu; T Yamane; T Karino; R Hamazoe; Y Osaki; H Kanayama; M Maeta; S Koga
Journal:  Jpn J Surg       Date:  1983-07

7.  Prospective study of natural cytotoxicity in peripheral blood of patients with nonlymphoid solid malignancies.

Authors:  L D Stewart; E W Ades
Journal:  Clin Immunol Immunopathol       Date:  1984-04

8.  Natural cytotoxic reactivity of peripheral blood lymphocytes from digestive tract cancer patients against a colon cancer cell line and virus-infected HeLa cells.

Authors:  N Tanaka; T Hashimoto; T Matsui; J Ohida; M Ono; K Orita
Journal:  Gan       Date:  1983-06

9.  Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.

Authors:  R H Wiltrout; R B Herberman; S R Zhang; M A Chirigos; J R Ortaldo; K M Green; J E Talmadge
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

10.  Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice.

Authors:  J E Talmadge; K M Meyers; D J Prieur; J R Starkey
Journal:  J Natl Cancer Inst       Date:  1980-11       Impact factor: 13.506

View more
  9 in total

1.  Decreased NKG2D expression on NK cells correlates with impaired NK cell function in patients with gastric cancer.

Authors:  Hiroaki Saito; Tomohiro Osaki; Masahide Ikeguchi
Journal:  Gastric Cancer       Date:  2011-05-31       Impact factor: 7.370

2.  Intracellular poly(I:C) initiated gastric adenocarcinoma cell apoptosis and subsequently ameliorated NK cell functions.

Authors:  Jing Qu; Zhaohua Hou; Qiuju Han; Wen Jiang; Cai Zhang; Zhigang Tian; Jian Zhang
Journal:  J Interferon Cytokine Res       Date:  2013-09-13       Impact factor: 2.607

3.  Increased apoptosis and elevated Fas expression in circulating natural killer cells in gastric cancer patients.

Authors:  Hiroaki Saito; Seigo Takaya; Tomohiro Osaki; Masahide Ikeguchi
Journal:  Gastric Cancer       Date:  2012-11-22       Impact factor: 7.370

4.  Natural killer cell activity in patients with pernicious anemia.

Authors:  J A Vargas; M Alvarez-Mon; L Manzano; A Albillos; A Fernández-Corugedo; J C Gea-Banacloche; F M Gonzalez; A Durántez
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

Review 5.  Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy.

Authors:  Hyung-Joon Kwon; Nayoung Kim; Hun Sik Kim
Journal:  Exp Mol Med       Date:  2017-03-31       Impact factor: 8.718

6.  Correlation Between Natural Killer Cell Activity and Systemic Inflammatory Markers for Heterogeneous Cancer Patients Treated With Wheel Balance Cancer Therapy.

Authors:  Hwi-Joong Kang; Kyeore Bae; Jee-Hye Kim; Chong-Kwan Cho; Hwa-Seung Yoo
Journal:  Integr Cancer Ther       Date:  2017-07-17       Impact factor: 3.279

7.  Progressive Impairment of NK Cell Cytotoxic Degranulation Is Associated With TGF-β1 Deregulation and Disease Progression in Pancreatic Cancer.

Authors:  Eunsung Jun; Ah Young Song; Ji-Wan Choi; Hyeon Ho Lee; Mi-Yeon Kim; Dae-Hyun Ko; Hyo Jeong Kang; Seong Who Kim; Yenan Bryceson; Song Cheol Kim; Hun Sik Kim
Journal:  Front Immunol       Date:  2019-06-21       Impact factor: 7.561

8.  Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma.

Authors:  T Fukuura; C Miki; T Inoue; K Matsumoto; H Suzuki
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

9.  Assessment of NK Cell Activity Based on NK Cell-Specific Receptor Synergy in Peripheral Blood Mononuclear Cells and Whole Blood.

Authors:  Jung Min Kim; Eunbi Yi; Hyungwoo Cho; Woo Seon Choi; Dae-Hyun Ko; Dok Hyun Yoon; Sang-Hyun Hwang; Hun Sik Kim
Journal:  Int J Mol Sci       Date:  2020-10-30       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.